Literature DB >> 23340443

More data, please!

Keith Baggerly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23340443      PMCID： PMC3746981          DOI： 10.1373/clinchem.2012.200501

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  10 in total

1.  Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.

Authors:  A Brazma; P Hingamp; J Quackenbush; G Sherlock; P Spellman; C Stoeckert; J Aach; W Ansorge; C A Ball; H C Causton; T Gaasterland; P Glenisson; F C Holstege; I F Kim; V Markowitz; J C Matese; H Parkinson; A Robinson; U Sarkans; S Schulze-Kremer; J Stewart; R Taylor; J Vilo; M Vingron
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

2.  Drug development: Raise standards for preclinical cancer research.

Authors:  C Glenn Begley; Lee M Ellis
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

Review 3.  Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting.

Authors:  Alain Dupuy; Richard M Simon
Journal:  J Natl Cancer Inst       Date:  2007-01-17       Impact factor: 13.506

4.  Much room for improvement in deposition rates of expression microarray datasets.

Authors:  Scott A Ochsner; David L Steffen; Christian J Stoeckert; Neil J McKenna
Journal:  Nat Methods       Date:  2008-12       Impact factor: 28.547

5.  Repeatability of published microarray gene expression analyses.

Authors:  John P A Ioannidis; David B Allison; Catherine A Ball; Issa Coulibaly; Xiangqin Cui; Aedín C Culhane; Mario Falchi; Cesare Furlanello; Laurence Game; Giuseppe Jurman; Jon Mangion; Tapan Mehta; Michael Nitzberg; Grier P Page; Enrico Petretto; Vera van Noort
Journal:  Nat Genet       Date:  2008-01-28       Impact factor: 38.330

6.  What information should be required to support clinical "omics" publications?

Authors:  Keith A Baggerly; Kevin R Coombes
Journal:  Clin Chem       Date:  2011-05       Impact factor: 8.327

Review 7.  Tackling the widespread and critical impact of batch effects in high-throughput data.

Authors:  Jeffrey T Leek; Robert B Scharpf; Héctor Corrada Bravo; David Simcha; Benjamin Langmead; W Evan Johnson; Donald Geman; Keith Baggerly; Rafael A Irizarry
Journal:  Nat Rev Genet       Date:  2010-09-14       Impact factor: 53.242

8.  Reporting recommendations for tumor marker prognostic studies (REMARK).

Authors:  Lisa M McShane; Douglas G Altman; Willi Sauerbrei; Sheila E Taube; Massimo Gion; Gary M Clark
Journal:  J Natl Cancer Inst       Date:  2005-08-17       Impact factor: 13.506

Review 9.  Data submission and quality in microarray-based microRNA profiling.

Authors:  Kenneth W Witwer
Journal:  Clin Chem       Date:  2013-02       Impact factor: 8.327

10.  Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments.

Authors:  Keith A Baggerly; Jeffrey S Morris; Kevin R Coombes
Journal:  Bioinformatics       Date:  2004-01-29       Impact factor: 6.937
  10 in total
  2 in total

1.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research.

Authors:  Kenneth W Witwer; Edit I Buzás; Lynne T Bemis; Adriana Bora; Cecilia Lässer; Jan Lötvall; Esther N Nolte-'t Hoen; Melissa G Piper; Sarada Sivaraman; Johan Skog; Clotilde Théry; Marca H Wauben; Fred Hochberg
Journal:  J Extracell Vesicles       Date:  2013-05-27

2.  Comparison of Methods for miRNA Extraction from Plasma and Quantitative Recovery of RNA from Cerebrospinal Fluid.

Authors:  Melissa A McAlexander; Maggie J Phillips; Kenneth W Witwer
Journal:  Front Genet       Date:  2013-05-16       Impact factor: 4.599
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.